The Breast and Gynecologic Cancer Research Group conducts and fosters the development of research on the prevention and early detection of breast cancer, cervix and human papillomavirus (HPV)-related cancers, endometrial cancers, ovarian cancers, and precursor conditions related to these cancers. New approaches to clinical prevention are investigated, including alternative dosing of agents to reduce side effects with similar efficacy, topical application of preventive agents for breast and cervical cancer, risk-reducing surgery for high-risk women, and cancer immunoprevention, including HPV vaccines.